Nephrogenic Systemic Fibrosis (NSF) Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1370542 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Nephrogenic Systemic Fibrosis (NSF) Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nephrogenic Systemic Fibrosis (NSF) Treatment Overall Market Size
    2.1 Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size: 2021 VS 2028
    2.2 Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Nephrogenic Systemic Fibrosis (NSF) Treatment Players in Global Market
    3.2 Top Global Nephrogenic Systemic Fibrosis (NSF) Treatment Companies Ranked by Revenue
    3.3 Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Nephrogenic Systemic Fibrosis (NSF) Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Nephrogenic Systemic Fibrosis (NSF) Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Nephrogenic Systemic Fibrosis (NSF) Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Nephrogenic Systemic Fibrosis (NSF) Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Nephrogenic Systemic Fibrosis (NSF) Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size Markets, 2021 & 2028
        4.1.2 Hemorrheologic Agents
        4.1.3 Immunomodulatory Drug
        4.1.4 Alkylating Agents
        4.1.5 Kinase Inhibitors
        4.1.6 Others
    4.2 By Type - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue & Forecasts
        4.2.1 By Type - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue & Forecasts
        5.2.1 By Application - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue & Forecasts
        6.2.1 By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2028
        6.3.2 US Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.3.3 Canada Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.3.4 Mexico Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2028
        6.4.2 Germany Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.4.3 France Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.4.4 U.K. Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.4.5 Italy Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.4.6 Russia Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.4.8 Benelux Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2028
        6.5.2 China Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.5.3 Japan Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.5.4 South Korea Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.5.6 India Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2028
        6.6.2 Brazil Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.6.3 Argentina Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2028
        6.7.2 Turkey Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.7.3 Israel Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
        6.7.5 UAE Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.1.4 Pfizer Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Sanofi
        7.2.1 Sanofi Corporate Summary
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.2.4 Sanofi Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.2.5 Sanofi Key News
    7.3 Allergan
        7.3.1 Allergan Corporate Summary
        7.3.2 Allergan Business Overview
        7.3.3 Allergan Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.3.4 Allergan Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.3.5 Allergan Key News
    7.4 Novartis
        7.4.1 Novartis Corporate Summary
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.4.4 Novartis Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.4.5 Novartis Key News
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Corporate Summary
        7.5.2 Johnson & Johnson Business Overview
        7.5.3 Johnson & Johnson Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.5.4 Johnson & Johnson Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.5.5 Johnson & Johnson Key News
    7.6 Bausch Health
        7.6.1 Bausch Health Corporate Summary
        7.6.2 Bausch Health Business Overview
        7.6.3 Bausch Health Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.6.4 Bausch Health Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.6.5 Bausch Health Key News
    7.7 Merck
        7.7.1 Merck Corporate Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.7.4 Merck Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.7.5 Merck Key News
    7.8 Teva Pharmaceuticals
        7.8.1 Teva Pharmaceuticals Corporate Summary
        7.8.2 Teva Pharmaceuticals Business Overview
        7.8.3 Teva Pharmaceuticals Nephrogenic Systemic Fibrosis (NSF) Treatment Major Product Offerings
        7.8.4 Teva Pharmaceuticals Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global Market (2017-2022)
        7.8.5 Teva Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Nephrogenic Systemic Fibrosis (NSF) Treatment Market Opportunities & Trends in Global Market
    Table 2. Nephrogenic Systemic Fibrosis (NSF) Treatment Market Drivers in Global Market
    Table 3. Nephrogenic Systemic Fibrosis (NSF) Treatment Market Restraints in Global Market
    Table 4. Key Players of Nephrogenic Systemic Fibrosis (NSF) Treatment in Global Market
    Table 5. Top Nephrogenic Systemic Fibrosis (NSF) Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Nephrogenic Systemic Fibrosis (NSF) Treatment Product Type
    Table 9. List of Global Tier 1 Nephrogenic Systemic Fibrosis (NSF) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Nephrogenic Systemic Fibrosis (NSF) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 32. Pfizer Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Sanofi Corporate Summary
    Table 34. Sanofi Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 35. Sanofi Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Allergan Corporate Summary
    Table 37. Allergan Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 38. Allergan Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Novartis Corporate Summary
    Table 40. Novartis Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 41. Novartis Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Johnson & Johnson Corporate Summary
    Table 43. Johnson & Johnson Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 44. Johnson & Johnson Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Bausch Health Corporate Summary
    Table 46. Bausch Health Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 47. Bausch Health Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Merck Corporate Summary
    Table 49. Merck Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 50. Merck Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Teva Pharmaceuticals Corporate Summary
    Table 52. Teva Pharmaceuticals Nephrogenic Systemic Fibrosis (NSF) Treatment Product Offerings
    Table 53. Teva Pharmaceuticals Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Nephrogenic Systemic Fibrosis (NSF) Treatment Segment by Type in 2021
    Figure 2. Nephrogenic Systemic Fibrosis (NSF) Treatment Segment by Application in 2021
    Figure 3. Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue in 2021
    Figure 8. By Type - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 12. US Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 24. China Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Sanofi Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Allergan Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novartis Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Johnson & Johnson Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Bausch Health Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Merck Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Teva Pharmaceuticals Nephrogenic Systemic Fibrosis (NSF) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Nephrogenic Systemic Fibrosis Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nephrogenic Systemic Fibrosis Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nephrogenic Systemic Fibrosis Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Groundfish Market

Groundfish are fish that live on, in, or near the bottom of the body of water they inhabit.� ... Read More